Specific cellular responses to α-tocopherol

Journal of Nutrition

Volumn 130, Issue 7, 2000, Pages 1649-1652

  Azzi, Angelo ^a   Breyer, Isabel ^a   Feher, Maria ^a   Pastori, Mariella ^a   Ricciarelli, Roberta ^a   Spycher, Stefan ^a   Staffieri, Mariagrazia ^a   Stocker, Achim ^a   Zimmer, Sabine ^a   Zingg, Jean Marc ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antioxidant; Cell proliferation; Gene expression; Protein kinase C; Vitamin E; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONATE 5 LIPOXYGENASE; BETA TOCOPHEROL; COLLAGENASE; CONNECTIVE TISSUE GROWTH FACTOR; DIACYLGLYCEROL KINASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE; PROBUCOL; PROTEIN KINASE C; SCAVENGER RECEPTOR;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITION; NEUTROPHIL; NONHUMAN; PROTEIN PROCESSING; REVIEW; THROMBOCYTE AGGREGATION;

EID: 17744405988     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.7.1649     Document Type: Review

References (74)

1. Evans H. M. & Bishop, K. S. (1922) Fetal resorption. Science (Washington, DC) 55: 650.
2. Epstein, S. S., Forsyth, J., Saporoschetz, I. B. & Mantel, N. (1966) An exploratory investigation on the inhibition of selected photosensitizers by agents of varying antioxidant activity. Radiat. Res. 28: 322-335.
3. Boscoboinik, D., Szewczyk, A. & Azzi, A. (1991) Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286: 264-269.
4. Boscoboinik, D., Szewczyk, A., Hensey, C. & Azzi, A. (1991) Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266: 6188-6194.
5. Ingold, K. U., Burton, G. W., Foster, D. O., Hughes, L., Lindsay, D. A. & Webb, A. (1987) Biokinetics of and discrimination between dietary RRR-and SRR-α-tocopherols in the male rat. Lipids 22: 163-172.
6. Bauernfeind, J. C., Rubin, S. H., Surmatis, J. D. & Ofner, A. (1970) Carotenoids and fat-soluble vitamins: contribution to food, feed and pharmaceuticals. Int. Z. Vitaminforsch. 40: 391-416.
7. Arita, M., Sato, Y., Miyata, A., Tanabe, T., Takahashi, E., Kayden, H. J., Arai, H. & Inoue, K. (1995) Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem. J. 306: 437-443.
8. Hosomi, A., Arita, M., Sato, Y., Kiyose, C., Ueda, T., Igarashi, O., Arai, H. & Inoue, K. (1997) Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409: 105-108.
9. Stocker, A., Hecht, H. J. & Buckmann, A. F. (1996) Synthesis, characterization and preliminary crystallographic data of N6-(6-carbamoylhexyl)-FAD-D-amino-acid oxidase from pig kidney, a semi-synthetic oxidase. Eur. J. Biochem. 238: 519-528.
10. Mukai, K., Daifuku, K., Yokoyama, S. & Nakano, M. (1990) Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim. Biophys. Acta 1035: 348-352.
11. Mooradian, A. D. (1993) Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45: 509-511.
12. Tesoriere, L., DArpa, D., Re, R. & Livrea, M. A. (1997) Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration. Arch. Biochem. Biophys. 343: 13-18.
13. Reppert, S. M., Weaver, D. R. & Godson, C. (1996) Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol. Sci. 17: 100-102.
14. Reiter, R. J. (1995) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9: 526-533.
15. Fisher, G. J. & Voorhees, J. J. (1996) Molecular mechanisms of retinoid actions in skin. FASEB J. 10: 1002-1013.
16. Wang, X. D. & Russell, R. M. (1999) Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr. Rev. 57: 263-272.
17. Bertram, J. S. (1993) Inhibition of chemically induced neoplastic transformation by carotenoids. Mechanistic studies. Ann. N.Y. Acad. Sci. 686: 161-175; discussion 175-166.
18. Esterbauer, H., Dieber Rotheneder, M., Striegl, G. & Waeg, G. (1991) Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53: 314S-321S.
19. Bowry, V. W., Ingold, K. U. & Stocker, R. (1992) Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288: 341-344.
20. x and complements α-tocopherol: physiological implications. Proc. Natl. Acad. Sci. U.S.A. 94: 3217-3222.
21. Goss, S.P.A., Hogg, N. & Kalyanaraman, B. (1999) The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite. Arch. Biochem. Biophys. 363: 333-340.
22. Azzi, A., Boscoboinik, D. & Hensey, C. (1992) The protein kinase C family. Eur. J. Biochem. 208: 547-557.
23. Azzi, A., Boscoboinik, D., Chatelain, E., Özer, N. K. & Stäuble, B. (1993) d-α-Tocopherol control of cell proliferation. Mol. Aspects. Med. 14: 265-271.
24. Chatelain, E., Boscoboinik, D. O., Bartoli, G. M., Kagan, V. E., Gey, F. K., Packer, L. & Azzi, A. (1993) Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta 1176: 83-89.
25. Boscoboinik, D., Chatelain, E., Bartoli, G. M. & Azzi, A. (1992) In: Free Radicals and Aging (Emerit, I. & Chance, B., eds.), pp. 164-177. Birkhäuser Verlag, Basel, Switzerland.
26. Tasinato, A., Boscoboinik, D., Bartoli, G. M., Maroni, P. & Azzi, A. (1995) d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad.Sci. U.S.A. 92: 12190-12194.
27. Devaraj, S., Li, D. & Jialal, I. (1996) The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Investig. 98: 756-763.
28. Devaraj, S., Adams-Huet, B., Fuller, C. J. & Jialal, I. (1997) Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation. Arterioscler. Thromb. Vasc. Biol. 17: 2273-2279.
29. Devaraj, S. & Jialal, I. (1998) The effects of alpha-tocopherol on critical cells in atherogenesis. Curr. Opin. Lipidol. 9: 11-15.
30. Freedman, J. E., Farhat, J. H., Loscalzo, J. & Keaney, J. F., Jr. (1996) α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94: 2434-2440.
31. Kanno, T., Utsumi, T., Kobuchi, H., Takehara, Y., Akiyama, J., Yoshioka, T., Horton, A. A. & Utsumi, K. (1995) Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. Free Radic. Res. 22: 431-440.
32. Koya, D., Lee, I. K., Ishii, H., Kanoh, H. & King, G. L. (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 8: 426-435.
33. Studer, R. K., Craven, P. A. & DeRubertis, F. R. (1997) Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925.
34. Tada, H., Ishii, H. & Isogai, S. (1997) Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 46: 779-784.
35. Martin-Nizard, F., Boullier, A., Fruchart, J. C. & Duriez, P. (1998) Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells. J. Cardiovasc. Risk 5: 339-345.
36. Cachia, O., El Benna, J., Pedruzzi, E., Descomps, B., Gougerot-Pocidalo, M. A. & Leger, C. L. (1998) α-Tocopherol inhibits the respiratory burst in human monocytes - attenuation of p47phox membrane translocation and phosphorylation. J. Biol. Chem. 273: 32801-32805.
37. Devaraj, S. & Jialal, I. (1999) Alpha-tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler. Thromb. Vasc. Biol. 19: 1125-1133.
38. Gey, K. F. (1990) The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms. Biochem. Soc. Trans. 18: 1041-1045.
39. Pryor, A. W., Comicelli, J. A., Devall, L. J., Tait, B., Trivedi, B. K., Witiak, D. T. & Wu, M. (1993) A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J. Org. Chem. 58: 3521-3532.
40. Ricciarelli, R., Tasinato, A., Clément, S., Özer, N. K., Boscoboinik, D. & Azzi, A. (1998) alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 334: 243-249.
41. Clement, S., Tasinato, A., Boscoboinik, D. & Azzi, A. (1997) The effect of alpha-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation. Eur. J. Biochem. 246: 745-749.
42. Azzi, A., Boscoboinik, D., Clement, S., Ozer, N., Ricciarelli, R. & Stocker, A. (1999) Vitamin E mediated response of smooth muscle cell to oxidant stress. Diabetes Res. Clin. Pract. 45: 191-198.
43. Kim, M. R. & Sok, D. E. (1991) Irreversible inhibition of soybean lipoxygenase-1 by hydroperoxy acids as substrates. Arch. Biochem. Biophys. 288: 270-275.
44. Azzi, A., Boscoboinik, D., Fazzio, A., Marilley, D., Maroni, P., Ozer, N. K., Spycher, S. & Tasinato, A. (1998) RRR-α-Tocopherol regulation of gene transcription in response to the cell oxidant status. Z. Ernaehrwiss. 37: 21-28.
45. Aratri, E., Spycher, S. E., Breyer, I. & Azzi, A. (1999) Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett. 447: 91-94.
46. Chojkier, M., Houglum, K., Lee, K. S. & Buck, M. (1998) Long-and short-term D-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression. Am. J. Physiol. 275: G1480-G1485.
47. Ricciarelli, R., Maroni, P., Ozer, N., Zingg, J. & Azzi, A. (1999) Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic. Biol. Med. 27: 729-737.
48. Shaw, H. M. & Huang, C. (1998) Liver α-tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. J. Nutr. 128: 2348-2354.
49. Teupser, D., Thiery, J. & Seidel, D. (1999) α-Tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 144: 109-115.
50. Ricciarelli, R., Zingg, J.-M. & Azzi, A. (2000) Downregulation of the CD36 scavenger receptor by α-tocopherol. Circulation (in press).
51. Azzi, A., Boscoboinik, D., Marilley, D., Özer, N. K., Stäuble, B. & Tasinato, A. (1995) Vitamin E: a sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62 (suppl.): 1337S-1346S.
52. Serbinova, E., Kagan, V., Man, D. & Packer, L. (1991) Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 10: 263-275.
53. Janero, D. A., Cohen, N., Burghardt, B. & Schaer, B. H. (1990) Novel 6-hydroxychroman-2-carbonitrile inhibitors of membrane peroxidative injury. Biochem. Pharm. 40: 551-558.
54. Williams, J. C., Forster, L. A., Tull, S. P., Wong, M., Bevan, R. J. & Ferns, G. A. (1997) Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia. Int. J. Exp. Pathol. 78: 259-266.
55. Saldeen, T., Li, D. & Mehta, J. L. (1999) Differential effects of alpha-and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis [In Process Citation]. J. Am. Coll. Cardiol. 34: 1208-1215.
56. Mabile, L., Bruckdorfer, K. R. & Rice-Evans, C. (1999) Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis 147: 177-185.
57. Islam, K. N., Devaraj, S. & Jialal, I. (1998) α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 98: 2255-2261.
58. Martin, A., Foxall, T., Blumberg, J. B. & Meydani, M. (1997) Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 17: 429-436.
59. Wu, D., Koga, T., Martin, K. R. & Meydani, M. (1999) Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 147: 297-307.
60. Yoshikawa, T., Yoshida, N., Manabe, H., Terasawa, Y., Takemura, T. & Kondo, M. (1998) α-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. Biofactors 7: 15-19.
61. Kanno, T., Utsumi, T., Takehara, Y., Ide, A., Akiyama, J., Yoshioka, T., Norton, A. A. & Utsumi, K. (1996) Inhibition of neutrophil-superoxide generation by α-tocopherol and coenzyme Q. Free Radic. Res. 24: 281-289.
62. • production in the promonocyte cell line THP-1 is essentially due to RRR-δ-tocopherol. Lipids 34 (suppl.): S293.
63. Wu, G. H., Jarstrand, C. & Nordenstrom, J. (1999) Phagocyte-induced lipid peroxidation of different intravenous fat emulsions and counteractive effect of vitamin E. Nutrition 15: 359-364.
64. Ben Hamida, C., Doerflinger, N., Belal, S., Under, C., Reutenauer, L., Dib, C., Gyapay, G., Vignal, A., Le Paslier, D. & Cohen, D. (1993) Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping (see comments). Nat. Genet. 5: 195-200.
65. Doerflinger, N., Linder, C., Ouahchi, K., Gyapay, G., Weissenbach, J., Le Paslier, D., Rigault, P., Belal, S., Ben Hamida, C., Hentati, F., Ben Hamida, M., Pandolfo, M., DiDonato, S., Sokol, R., Kayden, H., Landrieu, P., Durr, A., Brice, A., Goutières, F., Kohlschütter, A., Sabouraud, P., Benomar, A., Yahyaoui, M. & Mandel, J.-L. (1995) Ataxia with vitamin E deficiency: refinement of genetic localization and analysis of linkage disequilibrium by using new markers in 14 families. Am. J. Hum. Genet. 56: 1116-1124.
66. Gey, K. F. (1998) Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 7: 113-174.
67. Esterbauer, H., Schmidt, R. & Hayn, M. (1997) Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv. Pharmacol. 38: 425-456.
68. Gann, P. H., Ma, J., Giovannucci, E., Willett, W., Sacks, F. M., Hennekens, C. H. & Stampfer, M. J. (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59: 1225-1230.
69. Albanes, D., Heinonen, O. P., Huttunen, J. K., Taylor, P. R., Virtamo, J., Edwards, B. K., Haapakoski, J., Rautalahti, M., Hartman, A. M., Palmgren, J. & Greenwald, P. (1995) Effects of α-tocopherol and β-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 62 (suppl.): 1427S-1430S.
70. Park, J. Y., Ha, S. W. & King, G. L. (1999) The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit. Dial. Int. 19: S222-S227.
71. Kinlay, S., Fang, J. C., Hikita, H., Ho, I., Delagrange, D. M., Frei, B., Suh, J. H., Gerhard, M., Creager, M. A., Selwyn, A. P. & Ganz, P. (1999) Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation 100: 219-221.
72. Bursell, S. E. & King, G. L. (1999) Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? [In Process Citation]. Diabetes Res. Clin. Pract. 45: 169-182.
73. Yoshida, N., Yoshikawa, T., Manabe, H., Terasawa, Y., Kondo, M., Noguchi, N. & Niki, E. (1999) Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells. J. Leukoc. Biol. 65: 757-763.
74. Gu, M., Warshawsky, I. & Majerus, P. W. (1992) Cloning and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to retinaldehyde-binding protein and yeast SEC14p. Proc. Natl. Acad. Sci. U.S.A. 39: 2980-2984.